Skip to main content

.

Search

Dr. Neel Butala and Dr. C. Michael Gibson Discuss: Economic Outcomes and Cost-Effectiveness of TAVR for Asymptomatic Severe Aortic Stenosis: Results from the EARLY TAVR Trial

Disclosures: TBD